Beltapharm SPA DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

Teva, Sanofi say bowel disease drug met primary targets

18 Dec 2024

// PRESS RELEASE

FDA warns online vendors selling unapproved weight-loss drugs

18 Dec 2024

// REUTERS

Merck discontinues development of 2 experimental cancer drugs

18 Dec 2024

// REUTERS

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

Antibody Engineering

Not Confirmed

Book a meeting

envelop Contact Supplier

INSPECTIONS & REGISTRATIONS

2 FDA

inspections
2 FDA

About

BELTAPHARM S.p.A. was started in 1982 by a team of entrepreneurs with experience in the pharmaceutical field. Its scope is the production by contract manufacturing of pharmaceuticals for human. These are produced in the commonest pharmaceutical forms, mainly as generics (ex galenics), for export outside Europe (Africa, Asia and Latin America). Beltapharm S.p.A is approved as third-party manufacturer by several Italian and European companies for the production of pharmaceuticals in liquid and semi-solid forms, with a particular emphasis on steroid-based products like: cream,ointments and gels, both for human and veterinary use.